FDA inspection
SpineFrontier, Inc.: FDA inspection ending Nov 29, 2017
FDA inspection 1036897 · No Action Indicated (NAI) · Burlington, MA
Key facts
| Inspection ID | 1036897 |
|---|---|
| Firm | SpineFrontier, Inc. |
| FEI number | 3005977257 |
| Address | 350 Main St |
| City | Burlington |
| State | MA |
| ZIP | 01803 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Nov 29, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data